The Price of Invisibility
Why Fixing Women's Health Is the Fastest Route to Reducing Healthcare Spend
Women outlive men by five to six years on average, yet they spend 25 percent more of their lives in poor health. This research examines the economic consequences and proposes solutions.
Key Economic Findings
- •Closing the women's health gap could add at least $1 trillion to annual global GDP by 2040
- •In Switzerland, it costs 3.5 times more to save a woman's life than a man's due to systemic inefficiency
- •Employed women spend about $15 billion more each year out-of-pocket than employed men (excluding maternity)
- •Women pay 18% more annually in healthcare expenses than their male counterparts
- •For men, every $100 in health spending yields 2.62 months of additional life expectancy; for women, only 1.56 months
The Economic Paradox
Women outlive men in nearly every society on Earth, by five to six years on average, yet they spend 25 percent more of their lives in poor health. This paradox exposes a structural flaw in how modern healthcare is built and financed.
The system we've inherited was optimized for a different demographic reality—how diseases historically manifest in men as acute conditions. It is highly effective at prolonging life by treating acute, male-dominant conditions but remains ill-equipped to preserve function and quality of life, the domains where women disproportionately suffer.
The Functional Health Credit Framework
This research proposes a new framework: the Functional Health Credit. Under this model, payers and governments treat Healthy Life Years (HLYs) as creditable assets, measurable units of economic value. Insurers and public payers would reward early diagnostic interventions and functional-recovery pathways in women.
Each year of functional health preserved becomes a return on investment, not an expense. In macroeconomic terms, this reframes women's health from a cost center to a source of growth capital, one that strengthens the workforce, stabilizes public budgets, and extends national competitiveness.
The Cost of Diagnostic Delay
The greatest economic losses in women's health don't show up on hospital balance sheets—they show up in the labor market. The true cost is not medical spending, but time and capacity lost: the days off work, the diminished performance, the career stagnation that accumulates silently when symptoms go unrecognized.
Interested in the Economic Analysis?
Contact us to discuss how this research can inform your organization's approach to women's health economics.
Get in Touch